Host

Adriana Sánchez Danés, PhD, Cancer and Stem Cell Biology Lab

Venue

Seminar room

Abstract

In this seminar, I will present recent advances developed in our laboratory in CAR-based adoptive T-cell immunotherapy, with a particular focuss on leukemia. The talk will highlight γδ T cells as allogeneic effector platforms and explore emerging dual-targeting and armored CAR strategies.

The first edition of the Botton-Champalimaud International Pancreatic Conference, hosted at the prestigious Botton-Champalimaud Pancreatic Cancer Centre, was a landmark event in 2024, bringing together leading experts, researchers, and healthcare professionals from around the world to discuss the latest advancements in pancreatic cancer diagnosis, treatment, and care.

The Lucerne Consortium, a multidisciplinary group of European cancer societies and researchers that creates guidelines for early breast cancer care, published, in the December issue of the journal The Lancet Oncology, the conclusions of its Lucerne Toolbox 3 initiative, which pave the way to better treatment for patients in early stages of breast cancer.

The Lucerne consortium has already presented consensus recommendations for locoregional therapy after primary systemic therapy and for axillary management in early breast cancer. Now comes the turn of digital tools and AI.

Host

Carlos Ribeiro, PhD, Behavior and Metabolism

Venue

Seminar room

With more than three decades of pioneering work in breast cancer prevention, Dr Andrea De Censi, has joined the Champalimaud Foundation as the new Director of the Breast Unit. An internationally recognised medical oncologist and a leader in chemoprevention, Dr De Censi brings a vision that integrates prevention, clinical care and translational research in a patient-centred model.

Between February 2017 and December 2020, the team performed approximately 200 robotic procedures. Over the subsequent five years, from December 2020 to December 2025, this number more than doubled, reaching 500 procedures, an achievement that reflects the consolidation of a nationally recognised reference programme with extensive experience in robotic gynaecological surgery.

The symposium, themed "Neural and Immune Codes in Cancer" will gather an interdisciplinary community of researchers to discuss the interplay between the neural and immune systems in relation to cancer initiation, progression, defense and therapy. This symposium will emphasise the dynamic interactions among tumour cells, neurons and immune components, and how these relationships impact tumour growth, metastasis and the tumour microenvironment.

As a winner of the Outstanding Mid-Career Researcher Award, Inês Pires da Silva was recognised for her exceptional progress and global impact in translational cancer research. She has led international studies that have shaped current clinical practice and advanced scientific understanding of resistance mechanisms in immunotherapy.